PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.31%
Negative revenue growth while ECL.AX stands at 1.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-20.84%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
11.25%
Positive EBIT growth while ECL.AX is negative. John Neff might see a substantial edge in operational management.
11.25%
Positive operating income growth while ECL.AX is negative. John Neff might view this as a competitive edge in operations.
-11.48%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
No Data
No Data available this quarter, please select a different quarter.
1.20%
Slight or no buybacks while ECL.AX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-3.09%
Reduced diluted shares while ECL.AX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
260.14%
OCF growth above 1.5x ECL.AX's 32.99%. David Dodd would confirm a clear edge in underlying cash generation.
209.36%
FCF growth above 1.5x ECL.AX's 34.12%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-37.28%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
145.79%
5Y revenue/share CAGR above 1.5x ECL.AX's 61.63%. David Dodd would look for consistent product or market expansions fueling outperformance.
160.72%
3Y revenue/share CAGR above 1.5x ECL.AX's 44.25%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
127.83%
10Y OCF/share CAGR above 1.5x ECL.AX's 0.03%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
278.97%
5Y OCF/share CAGR above 1.5x ECL.AX's 13.67%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
253.00%
3Y OCF/share CAGR above 1.5x ECL.AX's 148.13%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
193.55%
Below 50% of ECL.AX's 1000.70%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
123.72%
Positive 5Y CAGR while ECL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
3.87%
Below 50% of ECL.AX's 56.68%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
719.84%
Positive 5Y equity/share CAGR while ECL.AX is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
104.09%
3Y equity/share CAGR above 1.5x ECL.AX's 16.09%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-91.28%
Firm’s AR is declining while ECL.AX shows 6.55%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
121.34%
We show growth while ECL.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
15.40%
Positive asset growth while ECL.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
14.90%
BV/share growth above 1.5x ECL.AX's 1.06%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-9.29%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
30.83%
We expand SG&A while ECL.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.